Form 8-K - Current report:
SEC Accession No. 0001493152-25-018460
Filing Date
2025-10-17
Accepted
2025-10-17 16:10:56
Documents
16
Period of Report
2025-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41067
2 EX-10.1 ex10-1.htm EX-10.1 1553
3 GRAPHIC ex10-1_001.jpg GRAPHIC 420067
4 GRAPHIC ex10-1_002.jpg GRAPHIC 71056
  Complete submission text file 0001493152-25-018460.txt   928654

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aimd-20251015.xsd EX-101.SCH 3736
6 XBRL DEFINITION FILE aimd-20251015_def.xml EX-101.DEF 26578
7 XBRL LABEL FILE aimd-20251015_lab.xml EX-101.LAB 36617
8 XBRL PRESENTATION FILE aimd-20251015_pre.xml EX-101.PRE 25202
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5621
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41461 | Film No.: 251400965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)